- Home
- NAUT vs RIV Comparison
NAUT vs RIV Comparison
Compare NAUT & RIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.62
Company Overview
Basic Information| Metric | NAUT | RIV |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.5M | 316.1M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | NAUT | RIV |
|---|---|---|
| Price | $2.62 | $11.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 312.1K | 68.1K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.85% |
| EPS Growth | ★ 16.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $992.86 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.62 | $10.93 |
| 52 Week High | $4.31 | $12.56 |
Technical Indicators
Market Signals| Indicator | NAUT | RIV |
|---|---|---|
| Relative Strength Index (RSI) | 40.21 | 58.32 |
| Support Level | $1.82 | $11.57 |
| Resistance Level | $3.18 | $11.74 |
| Average True Range (ATR) | 0.24 | 0.17 |
| MACD | -0.09 | 0.04 |
| Stochastic Oscillator | 9.83 | 80.29 |
Price Performance
Historical Comparison NAUT
RIV
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About RIV RiverNorth Opportunities Fund Inc.
Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.